tiprankstipranks
Trending News
More News >
Vaxil Bio Ltd (TSE:VXL)
:VXL
Canadian Market

Vaxil Bio (VXL) Income Statement

Compare
22 Followers

Vaxil Bio Income Statement

Last quarter (Q2 2025), Vaxil Bio's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Vaxil Bio's net income was C$42.00K. See Vaxil Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ -2.00KC$ -25.00KC$ -57.00K
Operating Expenses
C$ 196.00KC$ 254.00KC$ 584.00KC$ 986.00KC$ 1.35M
Depreciation and Amortization
C$ 196.00KC$ 2.00KC$ 2.00KC$ 25.00KC$ 57.00K
EBITDA
C$ -178.00KC$ -252.00KC$ -582.00KC$ -961.00KC$ -1.29M
Operating Income
C$ -196.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.35M
Other Income/Expenses
C$ 18.00KC$ 0.00C$ 0.00C$ 0.00C$ -11.00K
Pretax Income
C$ -178.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.36M
Net Income
C$ -178.00KC$ -254.00C$ -584.00KC$ -986.00KC$ -1.36M
Per Share Metrics
Basic EPS
C$ 0.00C$ 0.00C$ 0.00C$ -0.01C$ -0.01
Diluted EPS
C$ 0.00C$ 0.00C$ 0.00C$ -0.01C$ -0.01
Weighted Average Shares Outstanding
136.98M 137.00M 136.98M 136.10M 101.74M
Weighted Average Shares Outstanding (Diluted)
136.98M 136.98M 136.98M 136.10M 101.74M
Currency in CAD

Vaxil Bio Earnings and Revenue History